Back
Sep 27
Education

PRO 02 - Beyond the First Dose: Re-irradiation for Brain Tumors - Maximizing Outcomes and Managing Risk

09:30am - 10:45am PT

MODERATOR(S)

Stuart Burri, MD - Atrium Health Levine Cancer Institute

session DESCRIPTION

The session will explore the use of repeat radiation for intra-cranial neoplasms. The plan is to use an interactive case based approach to optimize audience engagement in the session. Radiation is the primary management modality for the treatment of a number of intracranial pathologies and the initial treatment is well studied and relatively standardized across the specialty. However, in the setting of recurrent disease, in a wide range of conditions, there is value of further radiation that currently is likely underutilized, but can benefit patients. This spans high grade malignant brain tumors such as glioblastoma as well as low grade primary brain tumors. Additionally, the management of meningioma can be challenging and the panel will discuss treatment strategies including emerging infusional radiopharmaceuticals. The management of brain metastases, as the most common intracranial malignancy, will be explored in the setting of re-irradiation. The panel will explore the gamut of technologies, including protons, in the presentation. Finally, the panel will discuss strategies and techniques to minimize risk as well as interventions to help manage potential toxicity.

learning objectives

  1. Determine which patients would benefit from re-irradiation of their primary or secondary brain tumor.
  2. Assess the various radiation techniques, technology and fractionation to optimally benefit patients while mitigating risk of toxicity.
  3. Analyze strategies to manage toxicities that may develop from re-irradiation.

Credits

AMA PRA Category 1 Credits: 1.25

Presentations